Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Oncology News Central. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncology News Central or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Empowered Choices: “The Most Important Conversations” Oncologists Can Have With NSCLC Patients

20:09
 
Share
 

Manage episode 493910682 series 3671392
Content provided by Oncology News Central. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncology News Central or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

When it comes to treatment decisions for patients with EGFR-mutated non-small cell lung cancer, “the most important conversations are not the data-driven ones, they are the relational ones,” says patient advocate Jill Feldman. In the second episode of the LungCancerRx video podcast, cohosts Fawzi F. Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit; Eric K. Singhi, MD, a thoracic oncologist in Houston; and Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O’Neal Cancer Center, ask Feldman about how physicians can better empower patients when making difficult therapy choices. “I started using ‘informed decision-making’ because you cannot have ‘shared decision-making’ if patients aren’t completely informed,” she explains.

  continue reading

2 episodes

Artwork
iconShare
 
Manage episode 493910682 series 3671392
Content provided by Oncology News Central. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncology News Central or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

When it comes to treatment decisions for patients with EGFR-mutated non-small cell lung cancer, “the most important conversations are not the data-driven ones, they are the relational ones,” says patient advocate Jill Feldman. In the second episode of the LungCancerRx video podcast, cohosts Fawzi F. Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit; Eric K. Singhi, MD, a thoracic oncologist in Houston; and Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O’Neal Cancer Center, ask Feldman about how physicians can better empower patients when making difficult therapy choices. “I started using ‘informed decision-making’ because you cannot have ‘shared decision-making’ if patients aren’t completely informed,” she explains.

  continue reading

2 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play